Citation Impact
Citing Papers
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
2010
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma
2007
The Dutch Deep Hyperthermia Trial: results in cervical cancer
2002
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
2007 Nature
Targeting HER proteins in cancer therapy and the role of the non-target HER3
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2007
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Autophagy in cancers including brain tumors: role of MicroRNAs
2020
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
2007
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
1999
A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer
2000
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
2010
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
2006 Nature
Heating the patient: a promising approach?
2002 Standout
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
2010
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Hyperthermia treatment planning
2000
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
A multispectral fluorescence imaging system: Design and initial clinical tests in intra‐operative Photofrin‐photodynamic therapy of brain tumors
2003
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
2007
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Facets and determinants of quality of life in patients with recurrent high grade glioma
2005
Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance
2005
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
2008
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Body mass and breast cancer: Relationship between method of detection and stage of disease
1996
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Brain tumors: molecular biology and targeted therapies
2006
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
Molecularly targeted therapy for malignant glioma
2007
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Advances in Brain Tumor Surgery
2007
Hyperthermia in oncology
2001
Adenovirus-mediated transfer of p53 augments hyperthermia-induced apoptosis in U251 glioma cells
2001
Concomitant Irradiation and Dose-Escalating Carboplatin for Locally Advanced Carcinoma of the Uterine Cervix
1998
A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma
1999
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
2001
The golden age: gold nanoparticles for biomedicine
2011 Standout
The Role of Surgery in Low Grade Gliomas
1999
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
2008
BRACHYTHERAPY FOR BRAIN TUMOR
1999
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
2001
Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium
2003
Salvage Chemotherapy with CPT-11 for Recurrent Glioblastoma Multiforme
2002
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
Hyperthermia, Radiation and Chemotherapy: The Role of Heat in Multidisciplinary Cancer Care
2014
Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme
2006
Inhibiting kinases in malignant gliomas
2007
Fluorescence-guided surgery with live molecular navigation — a new cutting edge
2013 Nobel
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.
1993
Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
2006
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors
1999
IMPACT OF INTRAOPERATIVE HIGH-FIELD MAGNETIC RESONANCE IMAGING GUIDANCE ON GLIOMA SURGERY
2009
Primary brain tumours in adults
2012 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Hyperthermic radiosensitization: mode of action and clinical relevance
2001
Antiangiogenic therapies for high-grade glioma
2009
Role of Radiation Therapy and Radiosurgery in Glioblastoma Multiforme
2003
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
2006
Cancer-related inflammation
2008 StandoutNature
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances
2006
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion
2011
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
2000
Magnetic Resonance Thermometry During Hyperthermia for Human High-Grade Sarcoma
1998
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
2001
Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas
1999
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Novel anti-angiogenic therapies for malignant gliomas
2008
Brain Tumors
2001 Standout
Prospective Phase I/II Studies of Definitive Irradiation and Chemotherapy for Advanced Gynecologic Malignancies
1996
Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium
2008
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: A pilot study
1992
Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications
2009 Standout
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
2001
Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study
2006
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
1999 Standout
Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution
2005
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
2008
Polyamines as Targets for Therapeutic Intervention
1995
Recent Advances on Surface Engineering of Magnetic Iron Oxide Nanoparticles and Their Biomedical Applications
2007
Angiogenesis as a Therapeutic Target in Malignant Gliomas
2009
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Size-Controlled Synthesis of Magnetite Nanoparticles
2002 Standout
General and Abdominal Obesity and Survival among Young Women with Breast Cancer
2006
Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles
2003 Standout
EGFR Activation Results in Enhanced Cyclooxygenase-2 Expression through p38 Mitogen-Activated Protein Kinase–Dependent Activation of the Sp1/Sp3 Transcription Factors in Human Gliomas
2007
Graphene-Like Two-Dimensional Materials
2013 Standout
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
2007
Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers
2007
Low grade glioma: a measuring radiographic response to radiotherapy.
1999
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
2008
Colloidosomes: Selectively Permeable Capsules Composed of Colloidal Particles
2002 StandoutScience
Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results
2005
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
2002
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
2007
Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments
2008
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
2007
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
2006
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas
2003
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas
1997
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
1999
Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas.
2000
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Matched Sampling for Causal Effects
2006
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
A Martingale Representation for Matching Estimators
2012 StandoutNobel
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
1999
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]
2000
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
2005
How effective is BCNU in recurrent glioblastoma in the modern era?
2004
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
2009
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
2003
Absorption by water increases fluorescence image contrast of biological tissue in the shortwave infrared
2018 StandoutNobel
The natural polyamine spermine functions directly as a free radical scavenger
1998 Standout
Works of Mary Malec being referenced
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme
1998
Treatment of Recurrent Gliomas With Eflornithine
1992
Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: A phase I–II prospective intergroup NCOG-RTOG study
1990
Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost
1994
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
2004
Proliferative potential and prognostic evaluation of low-grade astrocytomas
1994
Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience
1992
Long-Term Follow-Up after High-Activity <sup>125</sup>I Brachytherapy for Pediatric Brain Tumors
1996
Body size, reproductive factors, and breast cancer survival
1988
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group
1990
Intravenous Carboplatin for Recurrent Gliomas
1996
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1
2006
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
2001
Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib
2005
Radiation response and survival time in patients with glioblastoma multiforme
1996
A phase II study of intravenous carboplatin for the treatment of recurrent gliomas
1994
Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme
1996
Temozolomide in the treatment of recurrent malignant glioma
2004
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
1998
Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme
1998
Long-Term Survival in Patients with Glioblastoma Multiforme
1993
High activity iodine-125 interstitial implant for gliomas
1992
Large Effect of Age on the Survival of Patients with Glioblastoma Treated with Radiotherapy and Brachytherapy Boost
1995
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme
1996